The insulin-antagonistic effect of adrenaline was studied in seven healthy subjects with the euglycaemic clamp technique using two insulin infusion rates (40 and 1200 mU. (m 2)-l min-1). The adrenergic receptor mediating the adrenaline effect was characterized by concomitant infusion of propranolol
Characterization of the insulin-antagonistic effect of growth hormone in man
β Scribed by J. Fowelin; S. Attvall; H. von Schenck; U. Smith; I. Lager
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 666 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0012-186X
No coin nor oath required. For personal study only.
β¦ Synopsis
The insulin-antagonistic effect of growth hormone was characterized by infusing the hormone at three different infusion rates (6, 12 or 24mU.kg-*.min -1) for one h in 11 healthy subjects. The insulin effect was measured with the euglycaemic clamp technique combined with D-(3-3H)-glucose infusion to evaluate glucose production and utilization. A control study with NaC1 (154 mmol. 1 1) infusion was also performed. The insulin levels during the clamps were similar in all studies (36 + 0.2 mU-1 1). Peak growth hormone levels were reached at 60 min (growth hormone 6 mU. kg-1. h-l: 31 + 5; growth hormone 12 mU. kg 1. h-l: 52 + 4 and growth hormone 24 mU. kg -1. h-l: 102 + 8 mU. 1-0. The insulinantagonistic effect of growth hormone started after -2 h, was maximal after 4-5 h (-39% inhibition of glucose infusion rate between control and growth hormone 24 mU-kg -1. h-1) and lasted for 6-7 h after peak levels. The resistance was due to a less pronounced insulin effect both to inhibit glucose pro-duction and to stimulate glucose utilization. Growth hormone infusion of 12 mU. kg -I. h -1 induced a similar insulinantagonistic effect as the higher infusion rate whereas 6 mU. kg-1. h -1 induced a smaller response with a duration of 1 h between 3-4 h after peak levels of growth hormone. The present study demonstrates that growth hormone levels similar to those frequently seen in Type 1 (insulin-dependent) diabetic patients during poor metabolic control or hypoglycaemia, have pronounced insulin-antagonistic effects. The effects starts after about 2-3 h, is maximal after 4-5 h and lasts for about 6-7 h. Both duration and inhibitory effect of growth hormone are related to the plasma levels, where a maximal effect is seen at about 50 mU. 1 ~ or higher.
π SIMILAR VOLUMES
The metabolic effects of acute (4 h) and prolonged (24 h) growth hormone excess at pathophysiological concentrations were studied by growth hormone administration to normal subjects with and without somatostatin induced insulin deficiency. Acute growth hormone excess produced mild hyperinsulinaemia,